GAM Holding’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-11,836
Closed -$1.17M 853
2017
Q3
$1.17M Sell
11,836
-4,422
-27% -$429K 0.05% 335
2017
Q2
$1.65M Sell
16,258
-284
-2% -$30.6K 0.02% 540
2017
Q1
$1.91M Hold
16,542
0.03% 516
2016
Q4
$1.99M Buy
16,542
+14,232
+616% +$1.58M 0.03% 482
2016
Q3
$259K Hold
2,310
﹤0.01% 856
2016
Q2
$286K Buy
2,310
+754
+48% +$91K ﹤0.01% 855
2016
Q1
$175K Hold
1,556
﹤0.01% 891
2015
Q4
$169K Buy
1,556
+491
+46% +$56.2K ﹤0.01% 1043
2015
Q3
$106K Hold
1,065
﹤0.01% 1058
2015
Q2
$121K Buy
+1,065
New +$129K ﹤0.01% 1074
2015
Q1
Sell
-636
Closed -$77K 1110
2014
Q4
$77K Hold
636
﹤0.01% 1052
2014
Q3
$93K Sell
636
-9,700
-94% -$1.5M ﹤0.01% 1024
2014
Q2
$1.73M Buy
10,336
+9,500
+1,136% +$1.69M 0.03% 555
2014
Q1
$166K Hold
836
﹤0.01% 932
2013
Q4
$160K Hold
836
﹤0.01% 788
2013
Q3
$141K Hold
836
﹤0.01% 1002
2013
Q2
$127K Buy
+836
New +$118K ﹤0.01% 795

Other funds holding CLB

GAM Holding's CLB Position: Q4 2017 in Review

GAM Holding sold out of Core Laboratories (CLB) in Q4 2017, closing a stake of 11,836 shares — an estimated $1.17M sold.

GAM Holding first reported a position in CLB in Q2 2013 and held it in 17 quarters. The position peaked at $1.99M in Q4 2016. 356 funds tracked by Wall St. Rank hold CLB as of Q4 2017.

  • GAM Holding reported no remaining Core Laboratories position as of Q4 2017 after selling out during the quarter.
  • GAM Holding sold 11,836 Core Laboratories shares in Q4 2017, an estimated $1.17M.
  • GAM Holding first reported a position in Core Laboratories in Q2 2013 and held it in 17 quarters.
  • GAM Holding's Core Laboratories position peaked at $1.99M in Q4 2016.
  • 356 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2017.

Based on GAM Holding's 13F filing for Q4 2017, filed 14 Feb 2018.